Product image of Breyanzi (Lisocabtagene Maraleucel) supplied by GNH India

Breyanzi

Active Ingredient:
Lisocabtagene Maraleucel
Origin:
EU

Breyanzi (Lisocabtagene Maraleucel)

Breyanzi is a CAR T-cell therapy used for treating certain types of cancer. This advanced treatment involves modifying a patient's own immune cells to target cancer cells. Learn more about its uses and effects.

Manufacturer / TM Owner

Bristol-Myers Squibb Pharma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Breyanzi is primarily used in the treatment of specific types of cancer. It works by using the patient's own immune cells, which are genetically modified to recognize and attack cancer cells. This therapy is often considered when other treatments have not been effective. Patients and healthcare providers should discuss the specific indications and whether Breyanzi is suitable for their condition.

Side Effects

  • Breyanzi may cause various effects, including fever, fatigue, and low blood cell counts. These effects are generally managed by healthcare professionals. Patients should be monitored closely during and after treatment to ensure safety and efficacy.

Precautions & Warnings

  • Breyanzi should be administered under the supervision of a healthcare professional experienced in managing CAR T-cell therapies. Patients should be aware of potential side effects and discuss any concerns with their healthcare provider. Regular monitoring is essential to manage any adverse reactions effectively.

Avoid Interactions

  • Breyanzi may interact with other medications, including those that affect the immune system. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol and certain supplements may also impact the effectiveness of Breyanzi.

Frequently Asked Questions

Breyanzi is used for treating certain types of cancer by using the patient's own immune cells to target cancer cells.

Breyanzi is administered intravenously under the supervision of a healthcare professional.

Common effects of Breyanzi may include fever, fatigue, and low blood cell counts.

Patients with certain medical conditions or allergies should avoid Breyanzi. Consult a healthcare provider for personalized advice.

Breyanzi may interact with other medications. Always inform your healthcare provider about all medications you are taking.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lisocabtagene Maraleucel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT